Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Pharmacotherapeutics in dentistry- A review

Poonam Prakash

Her-2 neu expression in cervical intraepithelial neoplasia and carcinoma of cervix

Sugandha Chaudhary, Hema Pant, Ruchee Khandelwal, Surabhi Pandey, Nitish Garg

Surgical profile of patients with of benign breast disease at a tertiary care centre: A hospital based retrospective study

Vishwanath S Mogali, Prashanth Kumar B, Prashanth N Hudge, Arun Kumar Tukaram*

Ozenoxacin: A novel topical quinolone

Amar Shirsat, Bela Shah, Abhijit Trailokya

Prospective randomized double blinded comparative study on the effects of ephedrine and phenylephrine on fetal outcome and their effects on hypotension during elective cesarean section

R. Anitha Preethi, A. Pushparani

Posterior fossa midline mass lesions clinicopathological study and management

B Rajamohan, P Narasinga Rao

“Physical and chemical modified forms of palm shell: Preparation, characterization and preliminary assessment as adsorbents”

S. Kushawa, G. Sreelatha, and P. Padmaja

Relation between right ventricular function and the time of extubation after total repair of tetralogy of fallot in the pediatirc population

Gamal A Abdelhameed, Waleed I Ibraheem, Samar M Abdeltawab, Simon H Armanios

Study of her2/neu and ki-67 expression in invasive urothelial carcinoma of bladder and their correlation with grade and stage

Sohini Parveen Sarwala*, Ranu Sarkar, Moumita Maity